Defective Viral Genomes Arising In Vivo Provide Critical Danger Signals for the Triggering of Lung Antiviral Immunity

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Tapia, Karla ^a   Kim, Won keun ^a   Sun, Yan ^a   Mercado López, Xiomara ^a   Dunay, Emily ^a   Wise, Megan ^a   Adu, Michael ^a   López, Carolina B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD45 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3;

ANIMAL CELL; ARTICLE; DEFECTIVE VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOSTIMULATION; INFLUENZA A; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; VIRUS GENOME; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE; WESTERN BLOTTING;

ANIMALS; CRICETINAE; DOGS; GENOME, VIRAL; INFLUENZA A VIRUS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, KNOCKOUT; NF-KAPPA B; ORTHOMYXOVIRIDAE INFECTIONS; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SIGNAL TRANSDUCTION;

EID: 84887308873     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003703     Document Type: Article

References (54)

1. Baum A, Sachidanandam R, Garcia-Sastre A, (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proceedings of the National Academy of Sciences of the United States of America 107: 16303-16308.
2. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
3. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
4. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
5. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408.
6. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, et al. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34.
7. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, et al. (2009) Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 183: 3569-3573.
8. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, et al. (2012) Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell host & microbe 11: 607-616.
9. Huang AS, Baltimore D, (1970) Defective viral particles and viral disease processes. Nature 226: 325-327.
10. Lazzarini RA, Keene JD, Schubert M, (1981) The origins of defective interfering particles of the negative-strand RNA viruses. Cell 26: 145-154.
11. Von Magnus P, (1954) Incomplete forms of influenza virus. Adv Virus Res 2: 59-79.
12. Pathak KB, Nagy PD, (2009) Defective Interfering RNAs: Foes of Viruses and Friends of Virologists. Viruses 1: 895-919.
13. Nuesch JP, de Chastonay J, Siegl G, (1989) Detection of defective genomes in hepatitis A virus particles present in clinical specimens. The Journal of general virology 70 (Pt 12) (): 3475-3480.
14. Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, et al. (1991) Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology 183: 555-565.
15. Rosmorduc O, Petit MA, Pol S, Capel F, Bortolotti F, et al. (1995) In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 22: 10-19.
16. Noppornpanth S, Smits SL, Lien TX, Poovorawan Y, Osterhaus AD, et al. (2007) Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients. Journal of virology 81: 12496-12503.
17. Inoue M, Hoxie JA, Reddy MV, Srinivasan A, Reddy EP, (1991) Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Proc Natl Acad Sci U S A 88: 2278-2282.
18. Li D, Lott WB, Lowry K, Jones A, Thu HM, et al. (2011) Defective interfering viral particles in acute dengue infections. PLoS One 6: e19447.
19. Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, et al. (2013) Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. Journal of virology 87: 8064-8074.
20. Johnston MD, (1981) The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells. J Gen Virol 56: 175-184.
21. Marcus PI, Gaccione C, (1989) Interferon induction by viruses. XIX. Vesicular stomatitis virus-New Jersey: high multiplicity passages generate interferon-inducing, defective-interfering particles. Virology 171: 630-633.
22. Strahle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, et al. (2007) Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J Virol 81: 12227-12237.
23. Yount JS, Gitlin L, Moran TM, Lopez CB, (2008) MDA5 Participates in the Detection of Paramyxovirus Infection and Is Essential for the Early Activation of Dendritic Cells in Response to Sendai Virus Defective Interfering Particles. J Immunol 180: 4910-4918.
24. Yount JS, Kraus TA, Horvath CM, Moran TM, Lopez CB, (2006) A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol 177: 4503-4513.
25. Shingai M, Ebihara T, Begum NA, Kato A, Honma T, et al. (2007) Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 179: 6123-6133.
26. Lopez CB, Yount JS, Hermesh T, Moran TM, (2006) Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J Virol 80: 4538-4545.
27. Yount JS, Moran TM, Lopez CB, (2007) Cytokine-independent upregulation of MDA5 in viral infection. J Virol 81: 7316-7319.
28. Strahle L, Garcin D, Kolakofsky D, (2006) Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351: 101-111.
29. Re GG, Kingsbury DW, (1986) Nucleotide sequences that affect replicative and transcriptional efficiencies of Sendai virus deletion mutants. J Virol 58: 578-582.
30. Dimmock NJ, Kennedy SI, (1978) Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. J Gen Virol 39: 231-242.
31. Dimmock NJ, (1985) Defective interfering viruses: modulators of infection. Microbiol Sci 2: 1-7.
32. Dimmock NJ, Beck S, McLain L, (1986) Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. J Gen Virol 67 (Pt 5) (): 839-850.
33. Morgan DJ, McLain L, Dimmock NJ, (1993) Protection of three strains of mice against lethal influenza in vivo by defective interfering virus. Virus Res 29: 179-183.
34. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ, (2011) Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. The Journal of general virology 92: 2122-2132.
35. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ, (2011) Defective interfering virus protects elderly mice from influenza. Virology journal 8: 212.
36. Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, et al. (2010) Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS pathogens 6: e1000734.
37. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R, (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439: 344-348.
38. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proceedings of the National Academy of Sciences of the United States of America 101: 17264-17269.
39. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, et al. (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190-200.
40. Kato A, Kiyotani K, Sakai Y, Yoshida T, Nagai Y, (1997) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. The EMBO journal 16: 578-587.
41. Komatsu T, Takeuchi K, Yokoo J, Gotoh B, (2004) C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325: 137-148.
42. Park MS, Garcia-Sastre A, Cros JF, Basler CF, Palese P, (2003) Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77: 9522-9532.
43. Cadd T, Garcin D, Tapparel C, Itoh M, Homma M, et al. (1996) The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol 70: 5067-5074.
44. Garcin D, Curran J, Itoh M, Kolakofsky D, (2001) Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol 75: 6800-6807.
45. Sekellick MJ, Marcus PI, (1978) Persistent infection. I Interferon-inducing defective-interfering particles as mediators of cell sparing: possible role in persistent infection by vesicular stomatitis virus. Virology 85: 175-186.
46. Roux L, Holland JJ, (1979) Role of defective interfering particles of Sendai virus in persistent infections. Virology 93: 91-103.
47. Andzhaparidze OG, Bogomolova NN, Boriskin YS, Bektemirova MS, Drynov ID, (1981) Comparative study of rabies virus persistence in human and hamster cell lines. J Virol 37: 1-6.
48. Brinton MA, (1982) Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells. I. Generation of defective nonplaquing virus particles. Virology 116: 84-98.
49. Roos RP, Richards OC, Green J, Ehrenfeld E, (1982) Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol 43: 1118-1122.
50. van der Zeijst BA, Noyes BE, Mirault ME, Parker B, Osterhaus AD, et al. (1983) Persistent infection of some standard cell lines by lymphocytic choriomeningitis virus: transmission of infection by an intracellular agent. J Virol 48: 249-261.
51. Ogura T, Tanaka J, Kamiya S, Sato H, Ogura H, et al. (1986) Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J Gen Virol 67 (Pt 12) (): 2605-2616.
52. Moscona A, (1991) Defective interfering particles of human parainfluenza virus type 3 are associated with persistent infection in cell culture. Virology 183: 821-824.
53. Valdovinos MR, Gomez B, (2003) Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles. Intervirology 46: 190-198.
54. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, et al. (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. Journal of virology 83: 10309-10313.